Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1‐phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor‐positive breast cancer

Sphingosine kinase is an enzyme that catalyses the phosphorylation of sphingosine to form sphingosine 1‐phosphate. Sphingosine 1‐phosphate is a bioactive lipid, which has been shown to have an important role in promoting the survival, growth and invasiveness of cancer cells. Sphingosine 1‐phosphate binds to five different plasma membrane sphingosine 1‐phosphate receptors (S1P1–5) and can regulate intracellular target proteins. We have used immunohistochemical analysis to determine the concurrent expression levels of sphingosine kinase 1 or S1P receptors and other signaling proteins in estrogen receptor‐positive breast cancer tumors and have then assessed the impact of these combinations on clinical outcome. This approach has enabled identification of (i) novel biomarkers and (ii) several spatially controlled associations between either sphingosine kinase 1 or S1P1–3 and other signaling proteins whose combination affect prognosis. For instance, the translocation of sphingosine kinase 1 to the plasma membrane has been shown to be a critical determinant in cancer progression. However, our findings identify an additional novel role for the nuclear localization of sphingosine kinase 1 combined with either ERK‐1/2 or SFK or LYN or AKT or NF‐κB, which significantly shortens disease‐specific survival and/or recurrence. We also demonstrate that nuclear S1P2 receptor and c‐SRC are associated with improved prognosis and this is linked with a reduction in the nuclear localization of sphingosine kinase 1. These findings identify potential novel biomarker associations, which might serve as new targets for drug intervention designed to improve treatment of estrogen receptor‐positive breast cancer.

[1]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.

[2]  S. Pyne,et al.  Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. , 2011, Cancer research.

[3]  Charles D Smith,et al.  Ablation of Sphingosine Kinase-2 Inhibits Tumor Cell Proliferation and Migration , 2011, Molecular Cancer Research.

[4]  Y. Hannun,et al.  Defining a role for sphingosine kinase 1 in p53-dependent tumors , 2011, Oncogene.

[5]  S. Milstien,et al.  The outs and the ins of sphingosine-1-phosphate in immunity , 2011, Nature Reviews Immunology.

[6]  J. Trojanowski,et al.  BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate , 2011, The Journal of Neuroscience.

[7]  J. Alcorn,et al.  Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer , 2011, Investigational New Drugs.

[8]  S. Pitson,et al.  A critical role for the protein phosphatase 2A B'α regulatory subunit in dephosphorylation of sphingosine kinase 1. , 2011, The international journal of biochemistry & cell biology.

[9]  D. C. Simpson,et al.  Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  S. Pitson,et al.  Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis , 2011, Oncogene.

[11]  E. Mallon,et al.  High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. , 2010, The American journal of pathology.

[12]  Y. Fujiwara,et al.  Sphingosine 1-Phosphate Receptor 4 Uses HER2 (ERBB2) to Regulate Extracellular Signal Regulated Kinase-1/2 in MDA-MB-453 Breast Cancer Cells* , 2010, The Journal of Biological Chemistry.

[13]  E. Mallon,et al.  Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression , 2010, British Journal of Cancer.

[14]  R. Schiff,et al.  Sphingosine Kinase 1 Induces Tolerance to Human Epidermal Growth Factor Receptor 2 and Prevents Formation of a Migratory Phenotype in Response to Sphingosine 1-Phosphate in Estrogen Receptor-Positive Breast Cancer Cells , 2010, Molecular and Cellular Biology.

[15]  Cheng Luo,et al.  SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.

[16]  J. Pollack,et al.  LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. , 2010, Cancer research.

[17]  Cheng Luo,et al.  Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.

[18]  John M S Bartlett,et al.  Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients , 2009, Clinical Cancer Research.

[19]  Y. Khew-Goodall,et al.  Deactivation of Sphingosine Kinase 1 by Protein Phosphatase 2A* , 2008, Journal of Biological Chemistry.

[20]  T. Karn,et al.  Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer , 2008, Breast Cancer Research and Treatment.

[21]  S. Milstien,et al.  Filamin A Links Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 1 at Lamellipodia To Orchestrate Cell Migration , 2008, Molecular and Cellular Biology.

[22]  R. Sears,et al.  A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins , 2008, Cancer and Metastasis Reviews.

[23]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[24]  S. Milstien,et al.  Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. , 2007, Cancer research.

[25]  E. Goetzl,et al.  Distinctive T Cell-suppressive Signals from Nuclearized Type 1 Sphingosine 1-Phosphate G Protein-coupled Receptors* , 2007, Journal of Biological Chemistry.

[26]  J. Brown,et al.  Tumor Necrosis Factor-α-stimulated Cell Proliferation Is Mediated through Sphingosine Kinase-dependent Akt Activation and Cyclin D Expression* , 2007, Journal of Biological Chemistry.

[27]  G. Davis,et al.  Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling , 2006, Molecular Cancer.

[28]  Gabor Tigyi,et al.  The FASEB Journal express article 10.1096/fj.05-4810fje. Published online November 30, 2005. ©2005 FASEB , 2022 .

[29]  M. Golzio,et al.  Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. , 2005, Cancer research.

[30]  M. Zhang,et al.  SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism* , 2005, Journal of Biological Chemistry.

[31]  J. Bartlett,et al.  AKT activation predicts outcome in breast cancer patients treated with tamoxifen , 2005, The Journal of pathology.

[32]  A. Olivera,et al.  Early Activation of Sphingosine Kinase in Mast Cells and Recruitment to FcεRI Are Mediated by Its Interaction with Lyn Kinase , 2004, Molecular and Cellular Biology.

[33]  Debajit K. Biswas,et al.  NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis , 2004 .

[34]  J. R. Reeves,et al.  Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling , 2004, Breast Cancer Research.

[35]  M. Vadas,et al.  Activation of sphingosine kinase 1 by ERK1/2‐mediated phosphorylation , 2003, The EMBO journal.

[36]  Brian D. Lee,et al.  Discovery and evaluation of inhibitors of human sphingosine kinase. , 2003, Cancer research.

[37]  J. Frost,et al.  Phosphorylation of Raf-1 by p21-activated Kinase 1 and Src Regulates Raf-1 Autoinhibition* , 2003, The Journal of Biological Chemistry.

[38]  J. P. Hobson,et al.  Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. , 2002, Experimental cell research.

[39]  Weicheng Wu,et al.  Sphingosine Kinase Mediates Vascular Endothelial Growth Factor-Induced Activation of Ras and Mitogen-Activated Protein Kinases , 2002, Molecular and Cellular Biology.

[40]  Korey R. Johnson,et al.  PKC-dependent Activation of Sphingosine Kinase 1 and Translocation to the Plasma Membrane , 2002, The Journal of Biological Chemistry.

[41]  J. Gamble,et al.  Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-α Signaling* , 2002, The Journal of Biological Chemistry.

[42]  G. Mills,et al.  Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase* , 2001, The Journal of Biological Chemistry.

[43]  D. Fisher,et al.  A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. , 2001, Cancer research.

[44]  J. Gamble,et al.  An oncogenic role of sphingosine kinase , 2000, Current Biology.

[45]  S. Pyne,et al.  Sphingosine 1-phosphate signalling in mammalian cells , 2000 .

[46]  Y. Yatomi,et al.  EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition* , 1998, The Journal of Biological Chemistry.

[47]  S. Pyne,et al.  Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. , 2009, Cellular signalling.

[48]  S. Pyne,et al.  New aspects of sphingosine 1-phosphate signaling in mammalian cells. , 2009, Advances in enzyme regulation.

[49]  H. Nagawa,et al.  Sphingosine 1-Phosphate Receptor Expression Profile in Human Gastric Cancer Cells: Differential Regulation on the Migration and Proliferation1 , 2006 .

[50]  H. Nagawa,et al.  Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. , 2006, The Journal of surgical research.

[51]  Sankar Ghosh,et al.  NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Gamble,et al.  Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. , 2002, The Journal of biological chemistry.